SCHEMBL13626694

SCHEMBL13626694

CCN(c1cc(OC)c(OC)cc1[C@@H]1CCc2cc(O)ccc2C1)C(C)c1ccc(OCCN(C)C[C@@H]2CCCO2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.37
ESR2 Q92731 1/20 0.37
TP53 P04637 1/20 0.34
MAPT P10636 2/20 0.32
GAA P10253 2/20 0.32
RAB9A P51151 4/20 0.32
NPC1 O15118 3/20 0.32
MCHR1 Q99705 1/20 0.31
DRD2 P14416 4/20 0.31
DRD3 P35462 4/20 0.31
ALDH1A1 P00352 2/20 0.31
LMNA P02545 2/20 0.31
POLB P06746 1/20 0.31
DRD4 P21917 2/20 0.30
HTR1A P08908 1/20 0.30
MEN1 O00255 1/20 0.30
ADRB2 P07550 1/20 0.30
CYP2D6 P10635 1/20 0.30
CASP1 P29466 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626690 1.00 ESR1 (0.37) ESR1ESR2TP53MAPTGAA
SCHEMBL13626697 0.89 ESR1 (0.39) ESR1ESR2MAPTRAB9ADRD2
SCHEMBL13626666 0.88 ESR1 (0.42) ESR1ESR2MAPTRAB9ADRD2
SCHEMBL225332 0.87 ESR1 (0.52) ESR1ESR2TP53MAPTGAA
SCHEMBL225333 0.87 ESR1 (0.52) ESR1ESR2TP53MAPTGAA
SCHEMBL228651 0.87 ESR1 (0.52) ESR1ESR2TP53MAPTGAA
SCHEMBL13626681 0.86 ESR1 (0.40) ESR1ESR2MAPTRAB9ADRD2
SCHEMBL13626699 0.86 ESR1 (0.40) ESR1ESR2MAPTRAB9ADRD2
SCHEMBL13626652 0.86 ESR1 (0.41) ESR1ESR2TP53MAPTRAB9A
SCHEMBL13626657 0.86 ESR1 (0.41) ESR1ESR2TP53MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612114-B2 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed